Page 45 - Prostatis Group News Today

Neville Rodie & Shaw Inc. raised its position in Eli Lilly and Company (NYSE:LLY – Get Rating) by 35.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,630 shares of the company’s stock after acquiring an additional 690 shares during the […]

Carmichael Hill & Associates Inc. trimmed its position in shares of Honeywell International Inc. (NASDAQ:HON – Get Rating) by 12.3% during the 1st quarter, HoldingsChannel reports. The fund owned 2,694 shares of the conglomerate’s stock after selling 378 shares during the quarter. Carmichael Hill & Associates Inc.’s holdings in Honeywell International were worth $515,000 as […]

Prostatis Group LLC lessened its position in shares of Medtronic plc (NYSE:MDT – Get Rating) by 17.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,377 shares of the medical technology company’s stock after selling 5,318 shares during the […]

Prostatis Group LLC raised its holdings in shares of The Procter & Gamble Company (NYSE:PG – Get Rating) by 35.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 90,108 shares of the company’s stock after acquiring an additional 23,671 shares during the period. […]

JPMorgan Chase & Co. (NYSE:JPM) CEO Douglas B. Petno sold 4,930 shares of JPMorgan Chase & Co. stock in a transaction that occurred on Thursday, June 15th. The shares were sold at an average price of $142.16, for a total transaction of $700,848.80. Following the transaction, the chief executive officer now directly owns 277,161 shares […]

Prostatis Group LLC lifted its stake in Otis Worldwide Co. (NYSE:OTIS – Get Rating) by 1,404.4% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 153,566 shares of the company’s stock after buying an additional 143,358 shares during the quarter. Prostatis Group LLC’s holdings in Otis Worldwide were worth $154,000 at the end […]

Prostatis Group LLC cut its holdings in Vanguard Emerging Markets Government Bond ETF (NASDAQ:VWOB – Get Rating) by 4.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 13,005 shares of the company’s stock after selling 620 shares during the period. […]

Prostatis Group LLC purchased a new stake in shares of Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO – Get Rating) in the 4th quarter, HoldingsChannel reports. The fund purchased 5,814 shares of the exchange traded fund’s stock, valued at approximately $227,000. A number of other institutional investors have also modified their holdings of VWO. Mather Group […]

Prostatis Group LLC acquired a new stake in Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO – Get Rating) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 5,814 shares of the exchange traded fund’s stock, valued at approximately $227,000. A number of […]

Prostatis Group LLC lifted its position in shares of Altria Group, Inc. (NYSE:MO – Get Rating) by 148.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 201,537 shares of the company’s stock after buying an additional 120,572 shares during the period. […]